Strategic Mergers The recent merger between Particle Dynamics and EUROAPI UK positions Codis as a strengthened player with enhanced global manufacturing capabilities, presenting an opportunity to approach them for large-scale partnership or supply agreements.

Expanding Asset Base Significant investments in a new commercial spray drying facility in the UK indicate a focus on expanding manufacturing capacity, ideal for informing potential collaborations in synthesis, formulation, or contract manufacturing services.

Leadership Expansion New key appointments such as a Vice President of Sales and Marketing and a Chief Commercial Officer signal a strategic focus on growth and market penetration, making the company more receptive to sales propositions targeting pharmaceutical and nutraceutical clients.

Financial Growth With revenue estimates between 50 million and 100 million dollars, Codis is a growth-stage company actively investing in infrastructure and talent, representing an ideal target for enterprise-level solutions or partnership opportunities to support scaling needs.

Industry Collaborations Existing partnerships like the one with Univar Solutions demonstrate a pattern of collaboration within the pharmaceutical supply chain, opening opportunities for complementary supply chain, distribution, or value-added ingredient services.